Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Dialysis

 

Diaverum enters second new market of 2019

Soon-to-sell global dialysis provider Diaverum has bought an Albanian dialysis provider from investors and the country's dominant healthcare service group, marking its first entry into the small market. We talk to one of the selling party.

A poacher turns gamekeeper: Austrian health care reform     

After 19 years as a health care services expert working as an investment banker, analyst and consultant, Martin Brunninger has returned to his native Austria to become director-general for healthcare and social care. In this role, he is responsible for reforming the entire health and social care system under the new reformist conservative coalition government which came to power in December 2017 and is likely to hold power for a few years. We talk to Brunninger about the likely changes and his change in role.

Diaverum buys in Brazil

Global dialysis provider Diaverum has expanded its Brazilian footprint with another acquisition in Sao Paulo. Figures from the country's nephrology society indicate one in ten dialysis clinics are now owned by the international consolidators.

Integrated healthcare: What works, what doesn’t

What is integrated health care as practiced today in Europe? What can it deliver? And what are the barriers to its adoption>?  We look at the lessons from three large projects that have all run for over a decade - The Wigan Deal (UK), Tiohundra (Sweden) and Kinzigtal/OptiMedis (Germany). All three will present at the HBI Policy Summit, April 20-22, 2020, London. 

Interview: Peter Graf, CEO, Tiohundra

Uniquely, we think in Europe, Tiohundra, an organisation serving a municipality of 62,000, has fully merged social care and health care delivery. Social care (elderly care, disabled care, homecare, psychiatry) and health care (hospitals and primary care) – have been melded in to a single organisation. So what are the learnings? And are we going […]

Bridgepoint “exploring” €2bn sale/IPO of Diaverum

As first reported by HBI, dialysis group Diaverum looks certain to be sold by Bridgepoint. Reuters now suggests that Diaverum is "exploring" and "testing the appetite" for a €2bn sale of the global dialysis group Diaverum. We go through potential buyers.

B. Braun partner launches dialysis clinic in Ghana

Global dialysis supplier-provider B. Braun's Ghanian distributor, Engisys, has launched a private dialysis clinic in the capital Accra. We talk to its managing director about the local market.

Dialysis providers down in the dumps after Trump’s order

Trump's executive order on dialysis has been deemed a good thing for Davita and Fresenius Medical Care by the analyst and industry community. But their share prices have barely rebounded to their pre-announcement level at the time of writing, potentially indicating there is still some market wariness over what it means for them.

Renal Services CEO: “not for sale but anything is possible”

There are strong rumours that UK dialysis provider Renal Services will be put up for sale in the next 12 months. CEO and majority shareholder Stefano Ciampolini tells HBI that while there is no process or mandate at the moment, the group is mulling its options.

Find Us